Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosiglitazone Combinations in NASH
NCT00699036Phase 2Unknown
- Sponsor
- Brooke Army Medical Center
- Start
- Apr 2007
- Primary completion
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of rosiglitazone, metformin, losartan in Nonalcoholic steatohepatitis (NASH), sponsored by Brooke Army Medical Center. Status: unknown.
02
Drugs
rosiglitazonemetforminlosartan
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT00699036.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00699036.